Kakali Dhar

Kakali Dhar has extensive work experience in the field of bioanalysis and scientific research. Kakali is currently the Director of Bioanalysis, Platform Biology, and Bioanalysis at CytomX Therapeutics. Prior to this, they worked at Syngene International Limited as the Lead Scientist and HOD, where they led bioanalytical studies and implemented processes in alignment with regulatory guidelines. Kakali also served as the Senior Principal Scientist and Functional Head of Compliance, overseeing the execution of projects and ensuring adherence to guidelines. Kakali Dhar has also worked as an Associate Scientific Manager at Biocon, where they led a bioanalytical laboratory and collaborated with various stakeholders. Earlier in their career, they worked as a Cancer Research Biologist at the Kansas City VA Medical Center and as a Senior Research Associate at the National Institute of Cholera and Enteric Diseases.

Kakali Dhar received their Ph.D in Zoology with a specialization in Histopathology and Molecular Toxicology from the University of Kalyani. Kakali completed this degree from 1995 to 2001. Prior to that, they obtained their M.Sc in Zoology with a specialization in Cell Biology & Immunology from the same university in 1994. Additional certifications from Syngene International Limited and The Future of Labs & Awards are mentioned, but the details regarding their completion are not provided.